Gilbert Family Foundation Our Voice Play Video December 24, 2020 Seeking a True Cure: Developing Gene Replacement and Editing Therapies to Address the Cause of NF1 November 16, 2020 GFF’s Vision Restoration Initiative: Exploring Regenerative Therapies October 13, 2020 GFF’s Vision Restoration Initiative: Exploring Neuroprotection/Neuroenhancement Therapies September 14, 2020 GFF’s Guiding Values: Collaboration August 17, 2020 Nothing Nonsensical About Nonsense Mutations: GTI Researchers Target One of the Most Common Types of NF1 Disease-Causing Genetic Mutations July 13, 2020 NF Open Science Initiative – GFF’s New Partnership with Sage Bionetworks and Other NF Research Funders June 12, 2020 FDA Approves Selumetinib – What it Means for the NF Community and What’s Next? April 11, 2019 Gilbert Family Foundation Commits $11 Million to Combat Vision Loss in NF1 Patients December 12, 2018 Gilbert Family Foundation Announces $12 Million Gene Therapy Initiative to Address Underlying Cause of NF1
